221 related articles for article (PubMed ID: 16273808)
1. Rheumatoid arthritis databases in Finland.
Sokka T
Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S201-4. PubMed ID: 16273808
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excellent option in early rheumatoid arthritis.
Rantalaiho V; Puolakka K; Korpela M; Hannonen P; Möttönen T
Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S27-31. PubMed ID: 23073350
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid arthritis registries in Sweden.
van Vollenhoven RF; Askling J
Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S195-200. PubMed ID: 16273807
[TBL] [Abstract][Full Text] [Related]
4. Early Targeted Combination Treatment With Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Long-Term Outcomes in Rheumatoid Arthritis: Ten-Year Follow-Up Results of a Randomized Clinical Trial.
Rantalaiho V; Sandström T; Koski J; Hannonen P; Möttönen T; Kaipiainen-Seppänen O; Yli-Kerttula T; Kauppi MJ; Uutela T; Malmi T; Julkunen H; Laasonen L; Kautiainen H; Leirisalo-Repo M;
Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1450-1458. PubMed ID: 30295425
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid arthritis initial therapy: unanswered questions.
O'Dell J
J Rheumatol Suppl; 2005 Jan; 72():14-6. PubMed ID: 15660457
[TBL] [Abstract][Full Text] [Related]
6. An Early Rheumatoid Arthritis Treatment Evaluation Registry (ERATER) in the United States.
Sokka T; Pincus T
Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S178-81. PubMed ID: 16273804
[TBL] [Abstract][Full Text] [Related]
7. Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial.
Rantalaiho V; Kautiainen H; Järvenpää S; Korpela M; Malmi T; Hannonen P; Kaipiainen-Seppänen O; Yli-Kerttula T; Möttönen T; Mustila A; Karjalainen A; Paimela L; Uutela T; Leirisalo-Repo M;
J Rheumatol; 2014 Dec; 41(12):2379-85. PubMed ID: 25274892
[TBL] [Abstract][Full Text] [Related]
8. Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial.
Rantalaiho V; Kautiainen H; Korpela M; Hannonen P; Kaipiainen-Seppänen O; Möttönen T; Kauppi M; Karjalainen A; Laiho K; Laasonen L; Hakola M; Peltomaa R; Leirisalo-Repo M;
Ann Rheum Dis; 2014 Nov; 73(11):1954-61. PubMed ID: 23908187
[TBL] [Abstract][Full Text] [Related]
9. Databases of patients with early rheumatoid arthritis in the USA.
Sokka T; Willoughby J; Yazici Y; Pincus T
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S146-53. PubMed ID: 14969067
[TBL] [Abstract][Full Text] [Related]
10. ESPOIR and the French database management: what have we learned from the first years of follow-up?
Combe B
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-153-7. PubMed ID: 25365107
[TBL] [Abstract][Full Text] [Related]
11. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
[TBL] [Abstract][Full Text] [Related]
12. Early rheumatoid arthritis in Finland.
Sokka T
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S133-7. PubMed ID: 14969065
[TBL] [Abstract][Full Text] [Related]
13. Decline in work disability caused by early rheumatoid arthritis: results from a nationwide Finnish register, 2000-8.
Rantalaiho VM; Kautiainen H; Järvenpää S; Virta L; Pohjolainen T; Korpela M; Möttönen T; Puolakka K
Ann Rheum Dis; 2013 May; 72(5):672-7. PubMed ID: 22679306
[TBL] [Abstract][Full Text] [Related]
14. Treatment changes and improved outcomes in RA: an overview of a large inception cohort from 1989 to 2009.
Kievit W; Fransen J; de Waal Malefijt MC; den Broeder AA; van Riel PL
Rheumatology (Oxford); 2013 Aug; 52(8):1500-8. PubMed ID: 23657913
[TBL] [Abstract][Full Text] [Related]
15. Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study).
Leirisalo-Repo M; Kautiainen H; Laasonen L; Korpela M; Kauppi MJ; Kaipiainen-Seppänen O; Luosujärvi R; Luukkainen R; Karjalainen A; Blåfield H; Uutela T; Ilva K; Julkunen HA; Paimela L; Puolakka K; Moilanen E; Hannonen PJ; Möttönen T;
Ann Rheum Dis; 2013 Jun; 72(6):851-7. PubMed ID: 22753402
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life and continuation rate on first-line anti-tumour necrosis factor therapy among rheumatoid arthritis patients from the Australian Rheumatology Association Database.
Staples MP; March L; Lassere M; Reid C; Buchbinder R
Rheumatology (Oxford); 2011 Jan; 50(1):166-75. PubMed ID: 20929971
[TBL] [Abstract][Full Text] [Related]
17. The role of biologicals in early rheumatoid arthritis.
Haque UJ; Bathon JM
Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):179-89. PubMed ID: 15588978
[TBL] [Abstract][Full Text] [Related]
18. Assessment and management of rheumatoid arthritis.
Haraoui B
J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
[TBL] [Abstract][Full Text] [Related]
19. Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice.
Yamanaka H; Tohma S
Mod Rheumatol; 2006; 16(2):75-6. PubMed ID: 16633925
[TBL] [Abstract][Full Text] [Related]
20. DANBIO: a nationwide registry of biological therapies in Denmark.
Hetland ML
Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S205-7. PubMed ID: 16273809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
